Hemophilia A
Hematology · Specialty and rare-disease access
About Hemophilia A
An X-linked bleeding disorder caused by factor VIII deficiency.
Access to specialty treatment
Patients with Hemophilia A living in countries where their prescribed treatment is not registered or not reimbursed can explore Named Patient Program access. Reserve Meds coordinates this pathway: we work with your physician, help prepare destination-country documentation, and source the drug from DSCSA-compliant US wholesalers.
What to discuss with your physician
- Whether a specific US-approved drug is clinically appropriate for your case.
- Whether your treating physician can issue a prescription for NPP access.
- What documentation your destination country requires for the specific drug.
- Any dose, monitoring, or administration considerations.